Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)-Reference-Cited by-同舟云学术

Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)

Published:2000-08 Issue:8 Volume:24 Page:671-680
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Preisler Harvey D,Venugopal Parameswaran,Gregory S.A,Hsu Wei-Tong,Loew Jerome,Adler Solomon,Gezer Sefer,Creech Steve,Galvez Angel,Slivnick David,Andric Tanja,Larson Richard A,Jajeh Ahmad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. Acute myelogenous leukemia subsequent to therapy for a different neoplasm: clinical features and response to therapy;Preisler;Am. J. Haematol.,1977

2. Failure of remission induction in acute myelocytic leukemia;Preisler;Med. Pediatr. Oncol.,1978

3. Treatment failure in AML;Preisler;Blood Cells,1982

4. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome;Gajewski;J. Clin. Oncol.,1989

5. AML associated with previous cytotoxic therapy, MDS, or myeloproliferative disorders: results from the MRC’s 9th AML trial;Hoyle;Br. J. Haematol.,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML);Leukemia & Lymphoma;2011-09-13

2. Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant;Leukemia & Lymphoma;2010-06

3. Poor prognosis acute myelogenous leukemia: 3—biological and molecular biological changes during remission induction therapy;Leukemia Research;2001-09

4. High Remission Rate in Acute Myeloblastic Leukemia with Only Two Days of Chemotherapy;Leukemia & Lymphoma;2001-01

5. Current Awareness;Hematological Oncology;2001